416 related articles for article (PubMed ID: 17278894)
1. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Kut V; Spies W; Spies S; Gooding W; Argiris A
Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
[TBL] [Abstract][Full Text] [Related]
3. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study.
Chin R; McCain TW; Miller AA; Dunagan DP; Acostamadiedo J; Douglas Case L; Harkness BA; Adler LP; Haponik EF
Lung Cancer; 2002 Jul; 37(1):1-6. PubMed ID: 12057859
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
Cheran SK; Herndon JE; Patz EF
Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
[TBL] [Abstract][Full Text] [Related]
7. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Brink I; Schumacher T; Mix M; Ruhland S; Stoelben E; Digel W; Henke M; Ghanem N; Moser E; Nitzsche EU
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1614-20. PubMed ID: 15258700
[TBL] [Abstract][Full Text] [Related]
8. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
Kamel EM; Zwahlen D; Wyss MT; Stumpe KD; von Schulthess GK; Steinert HC
J Nucl Med; 2003 Dec; 44(12):1911-7. PubMed ID: 14660716
[TBL] [Abstract][Full Text] [Related]
9. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.
Shen YY; Shiau YC; Wang JJ; Ho ST; Kao CH
Anticancer Res; 2002; 22(2B):1257-64. PubMed ID: 12168935
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
Zhao DS; Valdivia AY; Li Y; Blaufox MD
Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis.
Fischer BM; Mortensen J; Langer SW; Loft A; Berthelsen AK; Petersen BI; Daugaard G; Lassen U; Hansen HH
Ann Oncol; 2007 Feb; 18(2):338-45. PubMed ID: 17060487
[TBL] [Abstract][Full Text] [Related]
12. Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Schmid RA; Hautmann H; Poellinger B; Kellner W; Moisseev A; Brinkbaeumer K; Weiss M; Hahn K; Dresel S
Nucl Med Commun; 2003 Jan; 24(1):37-45. PubMed ID: 12501018
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET imaging for the staging and follow-up of small cell lung cancer.
Schumacher T; Brink I; Mix M; Reinhardt M; Herget G; Digel W; Henke M; Moser E; Nitzsche E
Eur J Nucl Med; 2001 Apr; 28(4):483-8. PubMed ID: 11357499
[TBL] [Abstract][Full Text] [Related]
14. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
15. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
16. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
Niho S; Fujii H; Murakami K; Nagase S; Yoh K; Goto K; Ohmatsu H; Kubota K; Sekiguchi R; Nawano S; Saijo N; Nishiwaki Y
Lung Cancer; 2007 Sep; 57(3):328-33. PubMed ID: 17537538
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.
Arslan N; Tuncel M; Kuzhan O; Alagoz E; Budakoglu B; Ozet A; Ozguven MA
Ann Nucl Med; 2011 Jul; 25(6):406-13. PubMed ID: 21409347
[TBL] [Abstract][Full Text] [Related]
18. Can positron emission tomography be used as a staging tool for small-cell lung cancer?
Vinjamuri M; Craig M; Campbell-Fontaine A; Almubarak M; Gupta N; Rogers JS
Clin Lung Cancer; 2008 Jan; 9(1):30-4. PubMed ID: 18282355
[TBL] [Abstract][Full Text] [Related]
19. Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.
Sørensen JB; Ravn J; Loft A; Brenøe J; Berthelsen AK;
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1090-6. PubMed ID: 18799318
[TBL] [Abstract][Full Text] [Related]
20. When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy?
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Oct; 84(4):1092-7. PubMed ID: 17888953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
